Lundin Law PC announces it is investigating claims against Anavex Life
Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL)
concerning possible violations of federal securities laws. The
investigation is related to allegations that certain statements issued
by Anavex were false and misleading and/or failed to disclose material
information regarding the Company’s financial performance.
To participate in this class action lawsuit, please contact Brian
Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via email at brian@lundinlawpc.com.
The investigation will focus on whether the Company failed to disclose
that: (i) Anavex had used a paid stock promoter to artificially inflate
the Company's share price; and (ii) as a result of the foregoing,
Anavex's public statements were materially false and misleading at all
relevant times.
No class has been certified in the above action. Until a class is
certified, you are not considered represented by an attorney. You may
also choose to do nothing and be an absent class member.
Lundin Law PC was created by Brian Lundin, a securities litigator based
in Los Angeles.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160205005904/en/
Copyright Business Wire 2016